Почетна › Рак простате › Пенсилванија
Kliničke studije za Рак простате u državi Пенсилванија
62 studija za Рак простате traži učesnike na lokacijama u državi Пенсилванија.
Gradovi u državi Пенсилванија
- Philadelphia41 студија
- Pittsburgh23 студија
- Harrisburg8 студија
- Lancaster5 студија
- Erie5 студија
- York5 студија
- Scranton5 студија
- Hazleton4 студија
- Reading4 студија
- Allentown3 студија
- Chambersburg3 студија
Zvanični tekst studije (na engleskom)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- UPMC Altoona, Altoona
- UPMC-Heritage Valley Health System Beaver, Beaver
- Carlisle Regional Cancer Center, Carlisle
- и још 26
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 13. 11. 2026. · NCT04423211Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Thomas Jefferson University, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 12. 11. 2026. · NCT04221542Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Pocono Medical Center, East Stroudsburg
- и још 8
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03866382Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- MidLantic Urology, Bala-Cynwyd
Тражи се учесник
Узраст 18 и старији · Мушкарци · Ажурирано 12. 11. 2026. · NCT06511141Circulating Tumor DNA in High Risk Localized Prostate Cancer
- UPMC Hillman Cancer Center, Pittsburgh
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Мушкарци · Ажурирано 9. 11. 2026. · NCT07222436First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- GSK Investigational Site, Philadelphia
Тражи се учесникФаза 1/2
Узраст 18 и старији · Мушкарци · Ажурирано 9. 11. 2026. · NCT07332455Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Lancaster Urology, Lancaster
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 5. 11. 2026. · NCT07745361Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Geisinger Medical Center, Danville
- и још 7
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- University of Pittsburgh Medical Center, Pittsburgh
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07114601Distance-Based Exercise to Preserve Function and Prevent Disability
- UPMC Hillman Cancer Center at Butler Health System, Butler
- UPMC Hillman Cancer Center - Passavant - Cranberry, Cranberry Township
- IRMC Cancer Center, Indiana
- и још 6
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07059884A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- MidLantic Urology LLC, Bala-Cynwyd
- Keystone Urology Specialists, Lancaster
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT07723248A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT06095089Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Saint Vincent Hospital, Erie
- Jefferson Hospital, Jefferson Hills
- Forbes Hospital, Monroeville
- и још 8
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT06931340A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- UPMC, Pittsburgh
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 2. 11. 2026. · NCT07581184A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Perelman Center for Advanced Medicine ( Site 0067), Philadelphia
- Abramson Cancer Center - Penn Medicine ( Site 0079), Philadelphia
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 30. 10. 2026. · NCT06925737Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Penn State Milton S. Hershey Medical Center, Hershey
- Thomas Jefferson University Honickman Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
Тражи се учесникФаза 1
Узраст од 18 до 100 · Мушкарци · Ажурирано 29. 10. 2026. · NCT05519449Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 18 и старији · Мушкарци · Ажурирано 29. 10. 2026. · NCT05627219Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- UPMC-Heritage Valley Health System Beaver, Beaver
- Carlisle Regional Cancer Center, Carlisle
- Christiana Care Health System-Concord Health Center, Chadds Ford
- и још 24
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 23. 10. 2026. · NCT05946213Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
Тражи се учесник
Узраст 18 и старији · Мушкарци · Ажурирано 22. 10. 2026. · NCT05487846A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- MidLantic urology ( Site 0022), Bala-Cynwyd
- Fox Chase Cancer Center ( Site 0076), Philadelphia
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06136650A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Pittsburgh Medical Center, Pittsburgh
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 20. 10. 2026. · NCT07213674AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Pittsburgh
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 19. 10. 2026. · NCT07611110A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Hershey
- Research Site, Lancaster
- Research Site, Pittsburgh
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 14. 10. 2026. · NCT06952803This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- MidLantic urology, Bala-Cynwyd
- The Centers for Advanced Urology d/b/a Keystone Urology Specialist, Lancaster
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 14. 10. 2026. · NCT07028853Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Chambersburg Hospital, Chambersburg
- Geisinger Medical Center, Danville
- Ephrata Cancer Center, Ephrata
- и још 7
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 8. 10. 2026. · NCT03678025FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05919264The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
- WellSpan York Cancer Center, York
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750DESTINY-PANTUMOUR04
- Research Site, Philadelphia
Тражи се учесникОпсервациона студија
Узраст од 18 до 130 · Оба пола · Ажурирано 25. 9. 2026. · NCT07124000Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Fox Chase Cancer Center, Philadelphia
Тражи се учесникФаза 2/3
Узраст од 18 до 100 · Мушкарци · Ажурирано 22. 9. 2026. · NCT06780670Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 17. 9. 2026. · NCT04038502Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- Thomas Jefferson University, Philadelphia
- University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 15. 9. 2026. · NCT07493512Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
- Wellspan, Chambersburg
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT06138067Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
- Penn State Cancer Institute, Hershey
Тражи се учесникФаза 1/2
Узраст 40 и старији · Мушкарци · Ажурирано 31. 8. 2026. · NCT06600698A Study of Tarlatamab for People With Prostate Cancer
- Thomas Jefferson University Hospital, Philadelphia
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 31. 8. 2026. · NCT07111507A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 21. 8. 2026. · NCT06844383Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Thomas Jefferson University, Philadelphia
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 31. 7. 2026. · NCT06613100Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #109, Philadelphia
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 23. 7. 2026. · NCT06545942Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Christiana Care Health System-Concord Health Center, Chadds Ford
- Geisinger Medical Center, Danville
- Geisinger Cancer Center Dickson City, Dickson City
- и још 6
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 14. 7. 2026. · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- MidLantic Urology, Bala-Cynwyd
- Keystone Urology Specialists, Lancaster
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 9. 7. 2026. · NCT05413421A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Thomas Jefferson University Hospital, Philadelphia
Тражи се учесникФаза 1/2
Узраст 18 и старији · Мушкарци · Ажурирано 25. 6. 2026. · NCT06457919Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.